Search results
Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?
Zacks via Yahoo Finance· 13 hours agoOn Jun 10, the FDA's Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted...
FDA grants approval for Bristol Myers Squibb’s Augtyro for solid tumours
Pharmaceutical Technology via Yahoo Finance· 3 days agoThe treatment is indicated for use in adult and paediatric patients aged 12 years and above with...
FDA approves Amgen’s BLINCYTO for acute lymphoblastic leukaemia
Pharmaceutical Technology via Yahoo Finance· 3 days agoIn May 2024, Amgen‘s Bkemv (eculizumab-aeeb) received FDA approval for use as the first...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 7 days ago"FDA approves AstraZeneca’s Farxiga for paediatric T2D patients" was originally created and...
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
Zacks via Yahoo Finance· 15 hours agoZentalis' (ZNTL) three studies evaluating azenosertib for three different cancer indications face...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 1 day agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 and a 52-week maintenance study, COMMAND2Data showed that clinical remission,
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
Zacks via Yahoo Finance· 6 days agoThe FDA approves Bristol Myers' (BMY) cancer drug Augtyro for the treatment of adult and pediatric...
United Global Trading Corp. Announces ShieldON(R) EcoSeries Biodegradable Nitrile Gloves
Digital Journal· 13 hours agoPRESS RELEASE Published June 19, 2024 ACCESSWIRE FDA-Approved Single-Use Nitrile Gloves Break Down Faster Than Conventional Gloves LONG BEACH, CA / ACCESSWIRE ...
Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?
Zacks· 1 day agoOn Jun 10, the FDA's Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) voted 11-0, unanimously recommending the approval of Eli Lilly's (LLY) Alzheimer's disease drug, donanemab.
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate via Yahoo News· 7 days agoIf the FDA approves Lykos’ application in August, it would be the first time in the agency’s history...